ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mornex, J.
Right arrow Articles by Ecochard, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mornex, J.
Right arrow Articles by Ecochard, D
Eur Respir J 1994; 7: 779-785
Copyright © ERS Journals Ltd 1994


Original Articles

From granuloma to fibrosis in interstitial lung diseases: molecular and cellular interactions

JF Mornex, C Leroux, T Greenland, and D Ecochard

Granuloma is a feature of many chronic interstitial lung diseases, and may serve as a focus for subsequent fibrosis. Granulomas are composed of structured masses of cells of the macrophage lineage, which adopt an epithelioid aspect, interspersed with lymphocytes. They are formed around local centres of irritation. During their resolution, fibroblasts congregate around the structures and may penetrate the interior. In many cases, granulomas can disappear without leaving lasting traces. However, especially when damage has occurred to the surrounding tissue, permanent scarring and fibrosis may occur. Both types of cell present in the granuloma are capable of secreting a number of factors influencing the accumulation and proliferation of fibroblasts, both positively and negatively. The possible roles played by the different factors and, especially, interactions between them are discussed in the light of fibrosis formation. Possible therapeutic interventions are summarized.


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
T. E. Downing, T. A. Sporn, R. R. Bollinger, R. D. Davis, W. Parker, and S. S. Lin
Pulmonary Histopathology in an Experimental Model of Chronic Aspiration Is Independent of Acidity
Experimental Biology and Medicine, October 1, 2008; 233(10): 1202 - 1212.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Pantelidis, D.S. McGrath, A.M. Southcott, and R.M. du Bois
Single-cell analysis: a novel approach to tumour necrosis factor-{alpha} synthesis and secretion in sarcoidosis
Eur. Respir. J., November 1, 2002; 20(5): 1179 - 1184.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Paredi, S. A. Kharitonov, S. Loukides, P. Pantelidis, R. M. d. Bois, and P. J. Barnes
Exhaled Nitric Oxide Is Increased in Active Fibrosing Alveolitis
Chest, May 1, 1999; 115(5): 1352 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. T. Allen, C. A. Bloor, R. A. Knight, and M. A. Spiteri
Expression of Insulin-like Growth Factor Binding Proteins in Bronchoalveolar Lavage Fluid of Patients with Pulmonary Sarcoidosis
Am. J. Respir. Cell Mol. Biol., August 1, 1998; 19(2): 250 - 258.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the European Respiratory Society.